Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Molecular intelligence and immune reconnaissance in thyroid cancer: a new paradigm for diagnosis, risk stratification, and therapeutic precision
0
Zitationen
9
Autoren
2025
Jahr
Abstract
The field is converging toward an integrated framework that combines genomic architecture, immune contexture, and AI-derived features to refine surgical decisions, guide radioactive iodine use, and select systemic therapy. Near-term priorities include standardizing multi-omic pipelines, validating AI across diverse populations, and expanding access to testing, while emerging tools such as liquid biopsy and patient-derived organoids are poised to enable adaptive, patient-specific management.
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.077 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.720 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.830 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.349 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.012 Zit.